Incepbio Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-01-2025
- Paid Up Capital ₹ 0.28 M
as on 13-01-2025
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.30 Cr
as on 13-01-2025
- Revenue -25.63%
(FY 2022)
- Profit -42.00%
(FY 2022)
- Ebitda 4.64%
(FY 2022)
- Net Worth 12.10%
(FY 2022)
- Total Assets -8.38%
(FY 2022)
About Incepbio
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.28 M.
The company currently has active open charges totaling ₹2.30 Cr.
Subasha Prashanth, Ambarish Ghali, and Samit Deb serve as directors at the Company.
- CIN/LLPIN
U24304KA2016PTC094041
- Company No.
094041
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2016
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Incepbio Private Limited offer?
Incepbio Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Testing Services, Pharma & Bioanalytical Services, Pharmaceutical Services, Inspection & Quality Check Services, Food Certification Services, Agricultural & Farm Consultants, Agricultural Testing Service.
Who are the key members and board of directors at Incepbio?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samit Deb  | Director | 30-Nov-2016 | Current |
| Ambarish Ghali | Director | 10-Jun-2016 | Current |
| Subasha Prashanth | Director | 10-Jun-2016 | Current |
Financial Performance of Incepbio.
Incepbio Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 25.63% decrease. The company also saw a substantial fall in profitability, with a 42% decrease in profit. The company's net worth Soared by an impressive increase of 12.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Incepbio?
Unlock access to Incepbio's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prewel Labs Private LimitedActive 3 years 8 monthsSubasha Prashanth, Ambarish Ghali and 1 more are mutual person
Charges (Loans)
₹23.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.30 Cr
- Yes Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2023 | Hdfc Bank Limited | ₹1.30 Cr | Open |
| 30 Jun 2018 | Yes Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Incepbio?
Incepbio has a workforce of 53 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incepbio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incepbio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
